Simplex Trading’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History

Simplex Trading’s Portfolio HTGM Stock Details HTGM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-3	Closed	-$268	–	8781
2020 Q2	$0	Sell	3 -2	-40%	-$177	﹤0.01%	8630
2020 Q1	$0	Buy	+5	New	+$489	﹤0.01%	8509
2019 Q2	–	Sell	-4	Closed	-$1K	–	8062
2019 Q1	$1K	Sell	4 -19	-83%	-$8.32K	﹤0.01%	6976
2018 Q4	$10K	Sell	23 -143	-86%	-$88.6K	﹤0.01%	5870
2018 Q3	$151K	Buy	166 +165	+16,500%	+$109K	﹤0.01%	3963
2018 Q2	$0	Buy	+1	New	+$653	﹤0.01%	8064

Other funds holding HTGM

CPA

Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return

Samjo Capital New York $254M AUM 36.81% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BWLSA

Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Simplex Trading's HTGM Position: Q3 2020 in Review

Simplex Trading sold out of HTG Molecular Diagnostics, Inc. Common Stock (HTGM) in Q3 2020, closing a stake of 3 shares — an estimated $268 sold.

Simplex Trading first reported a position in HTGM in Q2 2018 and held it in 6 quarters. The position peaked at $151K in Q3 2018. 28 funds tracked by Wall St. Rank hold HTGM as of Q3 2020.

Simplex Trading reported no remaining HTG Molecular Diagnostics, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
Simplex Trading sold 3 HTG Molecular Diagnostics, Inc. Common Stock shares in Q3 2020, an estimated $268.
Simplex Trading first reported a position in HTG Molecular Diagnostics, Inc. Common Stock in Q2 2018 and held it in 6 quarters.
Simplex Trading's HTG Molecular Diagnostics, Inc. Common Stock position peaked at $151K in Q3 2018.
28 funds tracked by Wall St. Rank held HTG Molecular Diagnostics, Inc. Common Stock as of Q3 2020.

Based on Simplex Trading's 13F filing for Q3 2020, filed 14 Oct 2020.